ANXA2 and cancer: As Anxa2 expression and phosphor-Tyr23 are largely evaluated in various cancer types [16,17,18,19,20,21,34], this regulatory mechanism towards STAT3 somehow outstands as an assignable target for STAT3 inhibition.